A Study on the Necessity of Discontinuing Antiplatelet and Anticoagulant Therapy in Patients with Carpal Tunnel Syndrome

UMIN ID: UMIN000054675

Registered date:17/06/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Carpal Tunnel Syndrome
• Date of first enrollment: 2016/09/01
• Target sample size: 100
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

Antithrombotic drugs(Antiplatelet drugs + Anticoagulant drugs) Continuation
Antithrombotic drugs(Antiplatelet drugs + Anticoagulant drugs) interruption

Outcome(s)

• Primary Outcome: Patient-Rated Functional Assessment Scale:Carpal tunnel syndrome instrument-JSSH
• Secondary Outcome: Complications: Severe bleeding requiring reoperation, wound dehiscence, infection, cardiovascular events Swelling Assessment: Circumference measurements at the middle finger, hand, and wrist; VAS scores (patient and physician assessment) Grip Strength and Pinch Strength Sensory Evaluation: Semmes-Weinstein test Pain Assessment: VAS scores (patient and physician assessment)

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: 1 Patients who do not have the capacity to provide informed consent 2 Patients for whom it is not possible to obtain written consent 3 Patients who have not consistently taken antiplatelet or anticoagulant medications 4 Patients deemed unsuitable by the principal investigator or co-investigator, or those whose primary care physician deems it unsafe to discontinue antiplatelet or anticoagulant therapy

Related Information

• Primary Sponsor: others
• Source(s) of Monetary Support: nothing